MedTrace Logo

A Multicenter Cross-sectional Study on Tinnitus Subtypes and Risk Factors

NCT07383675 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3345

Last updated 2026-02-03

No results posted yet for this study

Summary

Tinnitus affects an estimated 10-15% of the global population and can substantially impair quality of life, yet clinically actionable approaches for subtype identification and risk stratification remain limited. This multicenter, cross-sectional observational study will use de-identified electronic health record (EHR) data from three otolaryngology specialty hospitals in China to address these gaps. All extracted data will be de-identified with direct identifiers removed, and privacy safeguards will be implemented in accordance with institutional policies and applicable regulations to protect patient confidentiality.

Conditions

  • Tinnitus

Interventions

OTHER

Observational group

This is a multicenter, cross-sectional observational study using existing electronic health record data collected during routine clinical care.We will use retrospectively extracted electronic health record data from multiple otolaryngology specialty hospitals to identify risk factors and develop predictive models for tinnitus subtypes at a single index time point.

Sponsors & Collaborators

  • Chongqing Renpin ENT. Hospital, China

    collaborator UNKNOWN

  • Nanjing Renpin ENT. Hospital, China

    collaborator UNKNOWN

  • Chengdu Renpin ENT. Hospital, China

    collaborator UNKNOWN

  • Shanghai Jiao Tong University School of Medicine

    lead OTHER

Principal Investigators

  • Hongsheng Tan, Dr · Shanghai Jiao Tong University School of Medicne

Eligibility

Min Age
18 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-01
Primary Completion
2024-11-30
Completion
2026-01-16

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07383675 on ClinicalTrials.gov